CSI Market
Sign In | Register

Bioage Labs Inc (BIOA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BIOA Annual Cash Flow →
Cash flow data covering Bioage Labs Inc–Jun 30 2025 offers a view into how Jun 30 2026's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-48.35
Depreciation & amortization0.10
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-1.39
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation8.53
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.31
Write Off Of Initial Public Offering Costs0.02
Interest And Debt Expense0.07
Non Cash Financial Charges Income Net-3.84
Revenue From Grants-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.14
Increase (Decrease) in Accounts Payable2.91
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets4.86
Other Working Capital-0.01
Other Noncash Income (Expense)0.00
Other net0.87
Payments for (Proceeds from) Other Operating Activities-10.98
Discontinued operations0.00
Net Cash flow from Operating Activities-43.31
Investing Activities
Capital Expenditures-0.35
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities73.08
Payments to Acquire Marketable Securities-284.00
Real Estate Investments0.00
Payments To Acquire Cost Method Investments-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-211.27
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.08
Long-term debt - borrowings-2.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.47
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net139.29
Proceeds From Government Grants-
Proceeds From Issuance Of Shares By Subsidiary-
Stock Repurchased And Retired During Period Value-
Proceeds From Issuance Of Short Term And Long Term Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities139.68
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-43.66
Total Cash Flow-114.92
4 historic quarters locked

Sign in to unlock the full Bioage Labs Inc cash flow history.

Sign In Create Free Account

About Bioage Labs Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-335407

Figures are derived from filed reports and may be restated. Historical data is subject to revision.